Antiviral drug 'Clevira' repurposed for treating mild to moderate Covid-19 patients
Antiviral drug 'Clevira' repurposed for treating mild to moderate Covid-19 patients Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate Covid-19 cases, the Chennai-based pharmaceutical company said. https://ift.tt/eA8V8J
No vaccines in Delhi, Kejriwal urges citizens not to queue up at inoculation centres tomorrow
No vaccines in Delhi, Kejriwal urges citizens not to queue up at inoculation centres tomorrow People aged 18 to 45 will be eligible for the Covid-19 vaccine from May 1 (tomorrow). https://ift.tt/eA8V8J
Encouraging Results For Alzheimer's Drug Repurposed For Fragile X Syndrome
Encouraging Results For Alzheimer's Drug Repurposed For Fragile X Syndrome
https://ift.tt/3ta7m5A April 30, 2021 at 03:34PM https://ift.tt/1R552o9
 |
submitted by /u/Maxcactus [link] [comments] |
Over 2.45 crore register for Phase 3 of Covid-19 vaccination
Over 2.45 crore register for Phase 3 of Covid-19 vaccination While more than 1.37 crore people registered themselves on April 28, more than 1.04 crore registered by the end of April 29. https://ift.tt/eA8V8J
Subscribe to:
Comments (Atom)